Ongoing EOI for Reproductive Health Commodities

UNFPA
Ongoing EOI for Reproductive Health Commodities Not set

Reference: Upcoming UNFPA Bid for Reproductive Health Commodities
Beneficiary countries or territories:
Published on: 05-Mar-2009
Deadline on: 05-Dec-2009 00:00 (GMT 0.00)

Description

Upcoming UNFPA Bid for Reproductive

Health Commodities

 

 This is an advance notification that UNFPA will conduct a bid for the following reproductive health commodities in the first half of 2009:

 

1. Oral hormonal contraceptives

- ethinylestradiol + levonorgestrel, tablet 30 micrograms + 150 micrograms

- levonorgestrel, tablet 30 micrograms

- levonorgestrel, tablet 750 micrograms (pack of two); 1.5 mg (pack of one)

 

2. Injectable hormonal contraceptives

- medroxyprogesterone acetate, depot injection 150 mg/ml, in 1-ml vial

- medroxyprogesterone acetate + estradiol cypronate, injection 25 mg + 5 mg

3. Implantable contraceptives

- two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg in total)

 

Goods must be supplied by World Health Organization (WHO) Prequalified and/or Stringent Regulatory Authority (SRA) approved facilities.

Pharmaceutical products offered must meet the requirements recommended by WHO, and are manufactured in compliance with current Good Manufacturing Practices (GMP).

 

All products offered must have submitted documents for WHO prequalification evaluation by the bid deadline, so we encourage suppliers to do so as early as possible

(see http://healthtech.who.int/pq/info_applicants/eoi/EOI_ReproductiveHealth-V3.pdf)

There is a fast track process in WHO pre-qualification for innovators’ products. (See:

http://healthtech.who.int/pq/info_applicants/Guidelines/GuideSubmittingDocFPPs_DRA_ICH_08_2005.pdf) 

 

Countries that participate in the International Conference on Harmonization (ICH) are considered as SRAs.

 

The bid will be open to primary manufacturers, or their authorized representatives, of the pharmaceutical products described, which are registered in the country where they are produced.

 

Goods are destined for many countries around the world, where UNFPA and its partners conduct reproductive health programs.

  

Approximate annual volumes and historical prices of the items are here:

 

Product

UoM

Annual Quantity

Price Range

Combined Low Dose Pills

Cycle

75,375,712

$0.16 - $0.63

Progestagen Pills

Cycle

7,334,640

$0.16 - $1.40

Emergency Contraceptive

Pack

1,518,586

$0.22 - $0.25

Injectable Contraceptives

Vial/Amp

31,090,313

$0.67 - $0.84

Implants

Set

433,760

$23.00 - $25.00

 

The bid will also require completion of a UN Pharmaceutical Questionnaire, with accompanying documents for each item formulation bid.

For products bid as alternatives to the products listed above, full justification is required, as mentioned on the questionnaire.

 

Estimated timing of the bid will be April, 2009, and the bid will be announced on UNGM. At the present, no further information is available.